Clean Levels in SMMT22 hold would be a good remount.
Swing AVWAP against recent highs are holding the stock.
22 gets a 24 push, then pullback to 22 and ideally get a catalyst
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.28USD
−614.93 MUSD
0.00USD
112.90 M
About Summit Therapeutics Inc.
Sector
Industry
Headquarters
Miami
Website
Founded
2003
FIGI
BBG00X3GQL76
Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.
Summit Therapeutics Inc.: Navigating the Bearish Phase After ATHAfter reaching an all-time high of $33.89, Summit Therapeutics Inc. seems to be entering a bearish phase. This shift raises questions about whether the stock will rebound or continue its downward trend. Historically, many biotech and therapeutics companies often experience pullbacks after substantia
SMMTLike it below $15. Unable to wait, so a bought a small position here at $21. Huge insider purchase of $75M. Hoping to keep it for 1+ year, DYOD risk is it can go to zero. Not a recommendation.
$SMMT Stock Surges on Positive Lung Cancer Drug Trial ResultsShares of Summit Therapeutics (NASDAQ: NASDAQ:SMMT ) surged dramatically, soaring to an all-time high after the biotech firm reported promising results from its Phase 3 trial of ivonescimab, an experimental lung cancer treatment. The news sent the stock up by as much as 75.2% during intraday tradin
$SMMT Support Level for Put SellingLooking to sell some weekly expiration puts on SMMT at the 9 strike price. I think we have room to fall but 9 seems like a nice level to pick up some shares should it make it. Nice premiums.
SMMT - risky Phase 2 play 03 22/2024Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiot
Uptrend becomes a trend lineThe key influencers of trends are the fundamental factors driving the underlying financial asset and market sentiment.
As an example of fundamental factors, the price development of a share can be a reflection of the company's economic strength.
Accordingly, a price increase may be due to the com
SMMT. We are going for the Peak of the Summit.SMMT. We are going for the Peak of the Summit.
High insider value. High institional value. Algo is loading.
After a big run like this, all of these low floats end up dudsAfter a big run like this, all of these low floats end up in the tank. Just speculating that this will follow tradition.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SMMT is 18.99 USD — it has increased by 2.15% in the past 24 hours. Watch Summit Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Summit Therapeutics Inc. stocks are traded under the ticker SMMT.
SMMT stock has fallen by −3.56% compared to the previous week, the month change is a −3.85% fall, over the last year Summit Therapeutics Inc. has showed a 868.88% increase.
We've gathered analysts' opinions on Summit Therapeutics Inc. future price: according to them, SMMT price has a max estimate of 44.00 USD and a min estimate of 23.00 USD. Watch SMMT chart and read a more detailed Summit Therapeutics Inc. stock forecast: see what analysts think of Summit Therapeutics Inc. and suggest that you do with its stocks.
SMMT reached its all-time high on Sep 16, 2024 with the price of 33.89 USD, and its all-time low was 0.66 USD and was reached on Dec 2, 2022. View more price dynamics on SMMT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SMMT stock is 6.34% volatile and has beta coefficient of 3.59. Track Summit Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Summit Therapeutics Inc. there?
Today Summit Therapeutics Inc. has the market capitalization of 13.70 B, it has decreased by −4.16% over the last week.
Yes, you can track Summit Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Summit Therapeutics Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
SMMT earnings for the last quarter are −0.05 USD per share, whereas the estimation was −0.07 USD resulting in a 25.10% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about Summit Therapeutics Inc. earnings.
Summit Therapeutics Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SMMT net income for the last quarter is −56.25 M USD, while the quarter before that showed −60.38 M USD of net income which accounts for 6.84% change. Track more Summit Therapeutics Inc. financial stats to get the full picture.
No, SMMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 105.00 employees. See our rating of the largest employees — is Summit Therapeutics Inc. on this list?
Like other stocks, SMMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Summit Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Summit Therapeutics Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Summit Therapeutics Inc. stock shows the buy signal. See more of Summit Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.